Valby, Denmark

Morten Jørgensen

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 72(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Morten Jørgensen: Innovator in Neurodegenerative Disease Treatment

Introduction

Morten Jørgensen is a prominent inventor based in Valby, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. With a total of 13 patents to his name, Jørgensen's work focuses on innovative compounds that aim to improve the lives of those affected by conditions such as Parkinson's Disease.

Latest Patents

Among his latest patents, Jørgensen has developed solid forms of a compound known as (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid. This compound serves as a prodrug of a catecholamine, which is intended for use in treating neurodegenerative diseases and disorders, including Parkinson's Disease. Additionally, he has patented catecholamine carbamate prodrugs that also target the treatment of Parkinson's Disease, providing new avenues for pharmaceutical compositions and methods of treatment.

Career Highlights

Morten Jørgensen is currently employed at H. Lundbeck A/S, a company renowned for its focus on brain diseases. His work at Lundbeck has allowed him to explore and develop innovative solutions for complex neurological conditions. His extensive research and development efforts have positioned him as a key figure in the pharmaceutical industry.

Collaborations

Jørgensen has collaborated with notable colleagues, including Klaus Gjervig Jensen and Martin Juhl. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of effective treatments.

Conclusion

Morten Jørgensen's contributions to the field of neurodegenerative disease treatment through his patents and collaborations highlight his commitment to improving patient outcomes. His work continues to pave the way for advancements in pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…